For example, in Alzheimer’s disease PCSK9 plays a direct role in the brain by lowering BACE1 expression and an indirect role by increasing LDL-C levels, which affects Aβ plaque formation and aggregation. This evidence concerns the gene PCSK9 and early-onset autosomal dominant Alzheimer disease.